SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae

A specific T-cell response persists in the majority of COVID-19 patients 6 months after hospital discharge. This response is more prominent in those who required critical care during the acute COVID-19 episode but is reduced in patients with lung sequelae.

Detalles Bibliográficos
Autores: Cruz, Tamara, Mendoza Barco, Núria, Perea, Lídia, Albacar Riobóo, Núria, González Navarro, E. Azucena, Hernández-González, Fernanda, Juan, Manel, Agustí García-Navarro, Àlvar, Sellarés Torres, Jacobo, Sibila Vidal, Oriol, Faner, Rosa
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/198563
Acceso en línea:https://hdl.handle.net/2445/198563
Access Level:acceso abierto
Palabra clave:SARS-CoV-2
Pneumònia
Pulmó
Cèl·lules T
Pneumonia
Lung
T cells
Descripción
Sumario:A specific T-cell response persists in the majority of COVID-19 patients 6 months after hospital discharge. This response is more prominent in those who required critical care during the acute COVID-19 episode but is reduced in patients with lung sequelae.

Similares en LA Referencia